You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
23 July 2021
Acquiring Amberen helped lift Alliance Pharma’s sales by around a quarter in the first half of 2021. The UK-based company said it had now completed integration of the Amberen brand into its US business.
29 June 2021
Alliance Pharma has announced that Kristof Neirynck of Walgreens Boots Alliance (WBA) is joining the company as an independent non-executive director on 1 December 2021.
15 April 2021
Futura Medical has reported its annual results, and Alliance Pharma is losing a non-executive director.
21 January 2021
Alliance Pharma said its Consumer Healthcare business had “performed well given the market backdrop” in 2020, with sales up by 1%. By contrast, the UK-based company’s Prescription Medicines business reported sales down by 14% due to the COVID-19 pandemic.
30 December 2020
Alliance Pharma has strengthened its consumer healthcare presence in the US by acquiring Biogix, including its Amberen brand, for USD110 million in cash.
24 September 2020
Alliance Pharma has divided its product portfolio into Consumer Healthcare brands and Prescription Medicines. The company said the Consumer Healthcare business generated sales of GBP43.8 million (USD55.8 million) in the first half of 2020, representing 67% of its total sales.
24 September 2020
Alliance Pharma remains keen to build its consumer healthcare presence through acquisitions, according to chief executive officer Peter Butterfield.
24 July 2020
Alliance Pharma reported sales down by 7% in the first half of 2020 as its prescription medicines business was affected by the COVID-19 pandemic. The UK-based company said sales of its consumer healthcare products “continued to be robust”.
25 March 2020
Alliance Pharma and Church & Dwight have issued statements on the potential financial impact of the COVID-19 pandemic.